Merck Company – Consensus Indicates Potential 15.2% Upside
Merck Company with ticker code (MRK) now have 20 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 125 and 85 with a mean TP of 100.85. Given that the stocks previous close was at 87.51 this now indicates there is a potential upside of 15.2%. There is a 50 day moving average of 88.84 while the 200 day moving average is 84.74. The market capitalisation for the company is $219,838m. Visit the company website at: https:||www.merck.com [stock_market_widget type="chart" template="basic" color="green" assets="MRK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $253,350m based on the market concensus. Merck Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.
Merck Company – Consensus Indicates Potential 15.2% Upside
Merck Company with ticker code (MRK) now have 20 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 125 and 85 with a mean TP of 100.85. Given that the stocks previous close was at 87.51 this now indicates there is a potential upside of 15.2%. There is a 50 day moving average of 88.84 while the 200 day moving average is 84.74. The market capitalisation for the company is $219,838m. Visit the company website at: https:||www.merck.com [stock_market_widget type="chart" template="basic" color="green" assets="MRK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $253,350m based on the market concensus. Merck Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.